Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| EU approves Onglyza diabetes drug for kidney cases - BusinessWeek |
 |
 |
|
BusinessWeek AstraZeneca PLC and Bristol-Myers Squibb Co. say their diabetes drug Onglyza has been approved in Europe for treating people with Type 2 diabetes who have moderate or severe renal impairment. The two companies said Friday that the approval from the |
